Search Within

GDMT, Medicine

  1. "Biostatistics Service"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (107)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (314)
  2. Department of Medicine (314)
  3. Epidemiology and Biostatistics (314)
  4. Gynecology Disease Management Team (314)
  5. Solid Tumor Oncology Division (310)
  6. Gynecologic Medicine Service (299)

More Groups

People
  1. Alexia Iasonos (186)
  2. Carol Aghajanian (143)
  3. Qin Zhou (143)
  4. Dennis Chi (81)
  5. Martee Hensley (80)
  6. Nadeem Abu-Rustum (78)

More People

Years
  1. 2025 (8)
  2. 2024 (25)
  3. 2023 (30)
  4. 2022 (29)
  5. 2021 (17)
  6. 2020 (24)

More Years

Publications
  1. Gynecologic Oncology (84)
  2. Journal of Clinical Oncology (74)
  3. International Journal of Gynecological Cancer (34)
  4. Cancer (12)
  5. Clinical Cancer Research (11)
  6. Breast Cancer Research and Treatment (7)

More Publications

Publishers
  1. Elsevier Inc. (93)
  2. American Society of Clinical Oncology (82)
  3. Lippincott Williams & Wilkins (36)
  4. American Association for Cancer Research (21)
  5. Wiley Blackwell (16)
  6. Springer (13)

More Publishers

Results (314)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 2 study of LY3023414 in patients with advanced endometrial cancer harboring activating mutations in the PI3K pathway
    Journal Article

    Rubinstein, M. M.; Hyman, D. M.; Caird, I.; Won, H.; Soldan, K.; Seier, K.; Iasonos, A.; Tew, W. P.; O’Cearbhaill, R. E.; Grisham, R. N.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Characteristics and survival of ovarian cancer patients treated with neoadjuvant chemotherapy but not undergoing interval debulking surgery
    Journal Article

    Liu, Y. L.; Filippova, O. T.; Zhou, Q.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V. A.; O'Cearbhaill, R. E.; more...
    Journal of Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer
    Journal Article

    Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Ovarian cancer care delivery: Diversity in public perception and access to care
    Meeting Abstract

    Cowan, R.; Esposito-Amery, P.; Seier, K.; Iasonos, A.; O'Cearbhaill, R.; Tew, W.; Jewell, E.; Brown, C.; Zivanovic, O.; Sonoda, Y.; more...
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers
    Meeting Abstract

    Cowan, R.; Pedra Nobre, S.; Zhou, Q.; Iasonos, A.; Long Roche, K.; Gardner, G.; Abu-Rustum, N.; Aghajanian, C.; Cadoo, K.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Surgical cytoreduction in advanced stage serous endometrial carcinoma
    Meeting Abstract

    Pedra Nobre, S.; Zhou, Q.; Iasonos, A.; Chi, D.; Makker, V.; Abu-Rustum, N.; Leitao, M.; Mueller, J.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Adjuvant enzalutamide for the treatment of early-stage androgen receptor-positive (AR plus ) TNBC
    Meeting Abstract

    Traina, T. A.; Boyle, L. A.; Arumov, A.; Patil, S.; Edelweiss, M.; DeFusco, P. A.; Gorsky, M.; Lamparella, N. E.; Modi, S.; Sanford, R. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save